The future of GWAS in drug discovery and biobank design

The future of GWAS in drug discovery and biobank design: are tools like isGWAS the solution to a pressing problem?

Zhana (from Optima Partners) presented on the 30th of November at University of Westminster for the London Bioinformatics Meetup. She talked about their work on isGWAS: While genome-wide association studies (GWAS) have proven a powerful tool for human geneticists, there is nevertheless, a dependency on sensitive individual-level data together with ever-increasing data sizes, limiting the GWAS approach from maximising potential. Here she presents in-silico GWAS (isGWAS), a uniquely scalable algorithm to infer regression parameters in case-control GWAS from cohort-level summary data.

You don't have to be a genomics expert for this talk, Zhana will provide enough context and introduction to appreciate the material.